- About Us
- Studies for Risk Management
- Consulting on Risk Management
- Other Research Services
- Public Health
- Study Recruitment
The Drug Safety Research Unit (DSRU) is an independent academic unit internationally respected for its work in Pharmacovigilance, Pharmacoepidemiology, Risk Management and Training for over 30 years.
In partnership with doctors in England, the DSRU, led by Director Professor Saad Shakir, aims to protect patients in primary and specialist care from unwanted adverse effects of newly marketed medicines using our unique methods of monitoring patients during the lifecycle of medicines.
DSRU Principal Research Fellow and pharmacist, Deborah Layton, attended the UK Clinical Pharmacy Association (UKCPA) conference in Nottingham. The UKCPA promotes expert practice in medicines management for the benefits of patients, the public and health care professionals by establishing standards, pharmacy workforce development and advancing innovation in all health care settings. Debbie promoted the work of the DSRU in general and our secondary care studies (SCEM) in particular. She also displayed a research poster on the results of a recent modified Prescription-Event Monitoring study (MPEM) on the drug utilisation of the atypical antipsychotic, Seroquel XL.